throbber
Paper No. ___
`Date Filed: Aug. 25, 2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`WOCKHARDT BIO AG,
`Petitioner,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner
`
`________________
`
`Case IPR2016-01582
`Patent 8,822,438
`
`________________
`
`
`JANSSEN ONCOLOGY, INC.’S MANDATORY NOTICES
`
`
`
`
`
`
`
`
`

`
`IPR2016-01582
`Patent 8,822,438
`
`Janssen Oncology, Inc. submits the following mandatory notices pursuant to
`
`37 C.F.R. §42.8.
`
`REAL PARTY-IN-INTEREST
`
`Janssen Oncology, Inc. (“Janssen”), a wholly-owned subsidiary of Johnson
`
`& Johnson (“J&J”), is a real party-in-interest. J&J, a publicly held company, is
`
`also a real party-in-interest. In addition, BTG International Limited, a subsidiary
`
`of BTG plc, is a real party-in-interest.
`
`RELATED MATTERS
`
`U.S. Patent 8,822,438 (the “’438 Patent”) issued from U.S. Application No.
`
`13/034,340 (the “’340 Application”). U.S. Patent Application No. 15/019,353,
`
`which is currently pending before the Office, claims the benefit of the ’340
`
`Application.
`
`The ’438 Patent was the subject of ex parte reexamination request No.
`
`90/020,096 (the “’096 reexamination”). On June 14, 2016, the Office issued a
`
`Notice of Termination of Preprocessing of the ’096 reexamination. As a result, the
`
`’096 reexamination will not be granted a filing date for failure to comply with the
`
`requirements of 37 C.F.R. § 1.501(a). See Ex. 2001.
`
`The ’438 Patent is the subject of the following inter partes reviews:
`
` IPR2016-00286, which was instituted on May 31, 2016 and was filed
`
`by Amerigen Pharmaceuticals Limited;
`
`2
`
`

`
`IPR2016-01582
`Patent 8,822,438
`
` IPR2016-01317, which was filed by Argentum Pharmaceuticals LLC
`
`on June 29, 2016; and
`
` IPR2016-01332, which was filed by Mylan Pharmaceuticals Inc. on
`
`June 30, 2016.
`
`The ’438 Patent is being asserted in the following patent infringement
`
`lawsuits:
`
` BTG International Limited, et al. v. Actavis Laboratories FL, Inc., et
`
`al., C.A. No. 2:15-cv-05909-KM-JBC (D.N.J.);
`
` Janssen Biotech, Inc., et al. v. Mylan Pharmaceuticals Inc., et al.,
`
`C.A. No. 1:15-cv-00130-IMK (N.D. W. Va.) (stayed; conditional trial
`
`date set for February 2018);
`
` BTG International Limited, et al. v. Amerigen Pharmaceuticals, Inc.,
`
`et al., C.A. No. 2:16-cv-02449-KM-JBC (D.N.J.); and
`
` BTG International Limited, et al. v. Glenmark Pharmaceuticals Inc.,
`
`USA et al., C.A. No. 2:16-cv-05909 (D.N.J.).
`
`The ’438 Patent was asserted in the following patent infringement lawsuits
`
`that have now been terminated:
`
` Janssen Biotech, Inc., et al. v. Par Pharmaceutical, Inc., et al., C.A.
`
`No. 1:15-cv-00679-SLR (D. Del.); and
`
`3
`
`

`
`IPR2016-01582
`Patent 8,822,438
`
` BTG International Limited, et al. v. Actavis Laboratories FL, Inc., et
`
`al., C.A. No. 9:15-cv-81076-DMM (S.D. Fla.).
`
`
`LEAD AND BACKUP COUNSEL
`
`Lead Counsel
`
`Dianne B. Elderkin (Reg. No. 28,598)
`delderkin@akingump.com
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1340
`Fax: (215) 965-1210
`
`
`Backup Counsel
`
`
`Barbara L. Mullin (Reg. No. 38,250)
`bmullin@akingump.com
`Ruben H. Munoz (Reg. No. 66,998)
`rmunoz@akingump.com
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1200
`Fax: (215) 965-1210
`
`
`
`4
`
`
`
`
`
`
`
`

`
`IPR2016-01582
`Patent 8,822,438
`
`SERVICE INFORMATION
`
`Janssen consents to electronic service at the following email address:
`
`JANS-ZYTIGA@akingump.com
`ZytigaIPRTeam@sidley.com
`
`
`
`Janssen may be served courtesy copies by postal mailing or hand-delivery as
`
`follows:
`
`
`
`Dianne B. Elderkin
`AKIN GUMP STRAUSS HAUER & FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1340
`Fax: (215) 965-1210
`
`
`
`Respectfully submitted,
`
`
`
`/s/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`Date: Aug. 25, 2016
`
`
`
`5
`
`

`
`IPR2016-01582
`Patent 8,822,438
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Janssen
`
`Oncology, Inc.’s Mandatory Notices as well as Exhibit 2001 were served on
`
`counsel of record on Aug. 25, 2016 by filing this document through the End-to-End
`
`System, as well as delivering a copy via electronic mail to counsel of record for the
`
`Petitioner at the following addresses:
`
`Dennies Varughese - dvarughe-PTAB@skgf.com
`Deborah A. Sterling - dsterlin-PTAB@skgf.com
`Christopher M. Gallo - cgallo-PTAB@skgf.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /s/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`Date: Aug. 25, 2016
`
`
`
`
`
`
`
`
`
`
`
`6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket